Advanced

Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

Agache, Ioana ; Annesi-Maesano, Isabella ; Bonertz, Andreas ; Branca, Francesco ; Cant, Andrew ; Fras, Zlatko ; Ingenrieth, Frank ; Namazova-Baranova, Leyla ; Odemyr, Mikaela and Spanevello, Antonio , et al. (2019) In Allergy: European Journal of Allergy and Clinical Immunology 74(11). p.2064-2076
Abstract

The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive... (More)

The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
allergic diseases, asthma, big data, environmental health, exposome, implementation science, quality criteria, translational research
in
Allergy: European Journal of Allergy and Clinical Immunology
volume
74
issue
11
pages
13 pages
publisher
Wiley-Blackwell
external identifiers
  • pmid:31070805
  • scopus:85067038591
ISSN
0105-4538
DOI
10.1111/all.13856
language
English
LU publication?
yes
id
e8a71a97-de77-437a-8b82-45029f3b83f2
date added to LUP
2019-07-04 13:10:53
date last changed
2020-07-08 04:59:02
@article{e8a71a97-de77-437a-8b82-45029f3b83f2,
  abstract     = {<p>The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.</p>},
  author       = {Agache, Ioana and Annesi-Maesano, Isabella and Bonertz, Andreas and Branca, Francesco and Cant, Andrew and Fras, Zlatko and Ingenrieth, Frank and Namazova-Baranova, Leyla and Odemyr, Mikaela and Spanevello, Antonio and Vieths, Stefan and Yorgancioglu, Arzu and Alvaro-Lozano, Montserat and Barber Hernandez, Domingo and Chivato, Tomás and Del Giacco, Stefano and Diamant, Zuzana and Eguiluz-Gracia, Ibon and van Wijk, Roy Gert and Gevaert, Philippe and Graessel, Anke and Hellings, Peter and Hoffmann-Sommergruber, Karin and Jutel, Marek and Lau, Susanne and Lauerma, Antti and Maria Olaguibel, Jose and O'Mahony, Liam and Ozdemir, Cevdet and Palomares, Oscar and Pfaar, Oliver and Sastre, Joaquin and Scadding, Glennis and Schmidt-Weber, Carsten and Schmid-Grendelmeier, Peter and Shamji, Mohamed and Skypala, Isabel and Spinola, Monica and Spranger, Otto and Torres, Maria and Vereda, Andrea and Bonini, Sergio},
  issn         = {0105-4538},
  language     = {eng},
  number       = {11},
  pages        = {2064--2076},
  publisher    = {Wiley-Blackwell},
  series       = {Allergy: European Journal of Allergy and Clinical Immunology},
  title        = {Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases},
  url          = {http://dx.doi.org/10.1111/all.13856},
  doi          = {10.1111/all.13856},
  volume       = {74},
  year         = {2019},
}